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Preface 
“How does the pregnant mother arrange to nourish a fetus within herself for 
many months that is an antigenically foreign body?” This question was raised by Sir 
Peter Brian Medawar in 1953. 
The relationship between mother and fetus fascinates me in the same way that it 
has fascinated reproductive immunologists for decades. 
A large amount of research has been performed in this area in early pregnancy. 
Nevertheless, the phenomena that occur at the end of pregnancy, on the day of 
delivery and the effects of pregnancy on the immune system after birth have not yet 
been completely clarified.  
Although an important number of discoveries in reproductive immunology have 
been documented in several animal models, the best model for human pregnancy 
remains the human female.  
Therefore, our research is not designed to address all of the unanswered 
questions surrounding the significance of the maternal immune system during 
pregnancy and its influence on fetal development. Rather, our goals are to identify 
the gaps in knowledge and to understand the roles of specific B and T cell subsets in 
the peripheral blood of women during the 3rd trimester of pregnancy, on the day of 
delivery and postpartum. Finally, we addressed whether normal labor has an effect 
on maternal circulating T cell subsets, regulatory T cells, and regulatory B cells. 
Research investigating reproductive immunology will advance our knowledge of 
immunology-related pregnancy complications and facilitate the design of novel 
therapies for reproductive pathologies. Overall, it might facilitate the design of new 
therapeutic approaches to control these complications and their impact on the health 
of the mother and child. 
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“You cannot create experience. You must undergo it” 
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Resumo 
A gravidez é um desafio para o sistema imunológico, porque tem de tolerar um 
feto geneticamente diferente e ao mesmo tempo proteger tanto a mãe como o feto 
contra ameaças biológicas. Isto requer uma regulação estreita dos vários tipos de 
células do sistema imunitário durante as diferentes fases da gravidez. Estudos 
recentes revelaram que determinadas subpopulações de células B e células T têm 
funções reguladoras e são essenciais para a manutenção da tolerância materno-fetal 
durante as fases iniciais da gravidez. No entanto, não está claro se as células do 
sistema imunológico materno, especialmente as recém descritas células reguladoras 
B (Breg) e T (Treg), também podem desempenhar um papel relevante no final da 
gravidez normal, no parto e no pós-parto. 
Com o objetivo de analisar o perfil imunológico desde o final da gravidez até ao 
pós-parto, foram efetuados três estudos observacionais que seguiram mulheres 
saudáveis, grávidas (n = 43) e não grávidas (como grupo controlo; n = 35), vigiadas 
na consulta externa do hospital CUF Descobertas. Em primeiro lugar, as contagens 
no sangue periférico das subpopulações de linfócitos B, considerando o perfil 
maturativo e incluindo as células Breg, foram analisadas em todas as mulheres 
grávidas durante o terceiro trimestre da gravidez, no dia do parto (imediatamente 
após o parto), e no pós-parto (pelo menos 6 semanas após o parto), e comparadas 
com as do grupo de mulheres não grávidas. Em segundo lugar, a evolução das 
subpopulações de células Treg foi avaliada no sangue periférico das mulheres 
grávidas nos mesmos pontos temporais do estudo anterior, e comparadas com as do 
grupo de controlo. Em terceiro lugar, o efeito do trabalho de parto sobre as 
subpopulações circulantes de células T, e sobre as subpopulações de células Treg e 
Breg, foi avaliado no dia do parto, comparando o subgrupo de mulheres grávidas que 
tiveram o parto por cesariana eletiva (sem trabalho de parto; n = 14), com as que 
tiveram um parto espontâneo vaginal (após o trabalho de parto; n = 18). 
A quantificação e a caracterização fenotípica de células B e células T foi 
efetuada por citometria de fluxo, de acordo com a expressão dos marcadores de 
superfície celular presentes nas suas diferentes subpopulações. Especificamente, as 
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subpopulações de células B foram caracterizadas no sangue periférico pela expressão 
de CD19 (marcador de células B), e pela expressão de IgD e CD38 para identificar o 
perfil maturativo dos linfócitos B de acordo com o sistema de classificação Bm1-5: 
células B de transição, células B naïve, células B de memória não switched, células B 
de memória switched entretanto divididas em células pós centro germinativo e 
células de memória em repouso, e ainda plasmablastos. Os linfócitos Breg foram 
caracterizados através da expressão de CD24, CD27, CD38, e a produção de IL-10 
foi avaliada após a estimulação com acetato de forbolmiristato (PMA), ionóforo de 
cálcio e lipopolissacárido (LPS) bacteriano. Relativamente às subpopulações de 
células T de sangue periférico, as células com expressão de CD3 (marcador de 
células T) que co-expressam CD4 (células T auxiliadoras) ou CD8 (células T 
citotóxicas) foram diferenciadas em naïve, memória central, memória efetoras, 
memória efetoras com diferenciação terminal utilizando os marcadores de superfície 
de células CD45RA e CD62L. A expressão de marcadores de ativação (HLA-DR e 
CD25) foi avaliada na população de linfócitos T totais e nas respetivas 
subpopulações de células T CD4 e CD8. Além disso, as células T natural killer 
(NKT)-like foram identificados pela co-expressão de CD3, CD16 e CD56. 
Finalmente, três estratégias analíticas foram utilizadas para caracterizar as células 
Treg (CD4DimCD25Hi, CD4+CD25HiCD127-/dim e CD4+CD25HiFoxp3+). Foi também 
efetuada a avaliação da expressão intracelular de Foxp3 na subpopulação de células 
Treg CD4DimCD25Hi. 
Os resultados mostraram que as contagens absolutas e percentuais dos linfócitos 
B foram significativamente mais baixas (p<0,05) nas mulheres grávidas no dia do 
parto, em comparação com as mulheres não grávidas. De uma forma geral, as 
contagens absolutas e percentagens da maioria das subpopulações de células B foram 
significativamente mais baixas (p<0,05) no terceiro trimestre da gravidez e no dia do 
parto. Além disso, essas contagens absolutas e percentuais das subpopulações de 
células B não tiveram diferenças significativas entre o período pós-parto e as 
mulheres não grávidas. No entanto, as exceções mais notáveis foram: as 
percentagens de células B naïve, que foram significativamente mais elevadas 
(p<0,05) no terceiro trimestre e no dia do parto do que no período pós-parto e o 
observado nas mulheres não grávidas; e as percentagens da subpopulação de células 
Breg CD24HiCD38Hi, que foram significativamente mais elevadas (p<0,05) no 
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período pós-parto do que no terceiro trimestre, no dia do parto e no grupo das 
mulheres não grávidas. 
De um modo semelhante às células Breg, as contagens absolutas de todas as 
subpopulações de células Treg foram significativamente maiores (p<0,05) no período 
pós-parto, em comparação com o terceiro trimestre da gravidez e com o dia do parto. 
Além disso, a expressão intracelular do fator de transcrição Foxp3 na subpopulação 
de células Treg CD4DimCD25Hi diminuiu significativamente (p<0,001) no terceiro 
trimestre da gravidez e no dia do parto em comparação com o observado nas 
mulheres não grávidas; e aumentou significativamente (p<0,001) no período pós-
parto, comparativamente com o terceiro trimestre de gravidez e com o dia do parto. 
Finalmente, verificou-se que as contagens absolutas e percentagens das 
subpopulações de células Breg e Treg circulantes não foram significativamente 
diferentes entre as mulheres que tiveram cesarianas eletivas (sem trabalho de parto) e 
aquelas que tiveram partos vaginais espontâneos (após o trabalho de parto). No 
entanto, as contagens absolutas dos linfócitos B e das células NKT-like foram 
significativamente menores (p<0,05) no sangue periférico das mulheres que tiveram 
parto vaginal. 
Concluiu-se que no sangue periférico os compartimentos de células B e T 
sofrem alterações quantitativas do final da gravidez normal até ao período pós-parto. 
Particularmente, as subpopulações de células Breg e Treg aumentam no período pós-
parto. Além disso, o trabalho de parto não parece ter um impacto sobre as 
subpopulações de células T e sobre as subpopulações de células Breg e Treg no 
sangue periférico materno. Portanto, estes resultados podem permitir uma melhor 
compreensão da imunomodulação que ocorre durante a gravidez humana e fornecem 
algumas evidências para o desenvolvimento de novas estratégias de diagnóstico e 
tratamento de patologias obstétricas. Estes resultados poderão contribuir para o 
estudo dos mecanismos de resposta materna à vacinação e à infeção. 
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Abstract 
The immune system is challenged during pregnancy because it must tolerate a 
genetically foreign fetus and protect both the mother and the fetus against biological 
threats. This achievement requires a tight regulation of the various immune system 
cell types during the different stages of pregnancy. Recent studies have reported that 
subsets of B cells and T cells have regulatory functions that are essential for the 
maintenance of tolerance during early pregnancy by suppressing the maternal 
alloreactivity against the fetus. However, it is unclear whether the maternal immune 
system cells, especially the recently described regulatory B cell (Breg) and T cell 
(Treg) subsets, can also play a relevant role in normal late pregnancy, labor and in 
postpartum period. 
To analyze the immunological profile from late pregnancy to postpartum, three 
observational studies have been performed encompassing the follow-up of healthy 
pregnant women (n = 43) and non-pregnant women (as a control group; n = 35) who 
were attending a hospital-based outpatient clinic (Hospital CUF Descobertas). First, 
the levels of peripheral blood B cell subsets, considering the different maturational 
stages and including Breg, were analyzed in all pregnant women during the 3rd 
trimester of pregnancy, on the day of delivery (immediately after labor), and in the 
postpartum period (at least 6 weeks after delivery), and compared with those of the 
non-pregnant women. Second, the variation in Treg subsets was assessed in 
peripheral blood of pregnant women at the same time points used in the previous 
study and compared with the control group. Third, the effect of labor on the 
peripheral blood T cell subsets and on the Treg and Breg subsets was assessed on the 
day of delivery, comparing the subgroup of pregnant women who gave birth by 
elective cesarean (no labor; n = 14) with those who had a spontaneous vaginal 
delivery (after labor; n = 18). 
Quantification and phenotypic characterization of B cells and T cells according 
to the expression of specific cell surface markers has been performed by flow 
cytometry. Specifically, circulating B cell subsets were characterized by the 
expression of CD19 (B cell marker) and by the expression of IgD and CD38 to 
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identify the different B cell maturational stages according to the Bm1-5 classification 
system: transitional B cells, naïve B cells, unswitched memory B cells and switched 
memory B cells, which were subsequently divided into post-germinal memory B 
cells and resting memory B cells; and plasmablasts. Breg subsets were characterized 
by the expression of CD24, CD27, CD38, and the production of IL-10 after phorbol 
12-myristate 13-acetate (PMA), calcium ionophore and lipopolysaccharide (LPS) 
stimulation. Regarding the circulating T cell subsets, cells expressing CD3 (T cell 
marker) and co-expressing either CD4 (helper T cells) or CD8 (cytotoxic T cells) 
were discriminated into naïve, central memory, effector memory, and terminally 
differentiated effector memory cells based on the cell surface markers CD45RA and 
CD62L. The expression of activation markers (HLA-DR and CD25) was assessed in 
total T lymphocytes and in CD4 and CD8 T cells subsets. In addition, natural killer T 
(NKT)-like cells were identified by the co-expression of CD3 with CD16 and CD56. 
Finally, three analytical strategies were used to characterize Treg cells 
(CD4DimCD25Hi, CD4+CD25HiCD127-/dim and CD4+CD25HiFoxp3+ T cells). 
Additionally, the expression levels of the transcription factor Foxp3 in the 
CD4DimCD25Hi Treg cells were analyzed. 
The results showed that the absolute counts and percentages of B cells were 
significantly lower (p<0.05) in pregnant women on the day of delivery compared 
with non-pregnant women. Overall, the absolute counts and percentages of the 
majority of the B cell subsets were significantly lower (p<0.05) in the 3rd trimester of 
pregnancy and on the day of delivery. Moreover, these counts and percentages did 
not differ significantly between the postpartum period and non-pregnant women. 
However, the most notable exceptions were the percentages of naïve B cells, which 
were significantly higher (p<0.05) in the 3rd trimester and on the day of delivery 
compared with the postpartum period and in non-pregnant women, and the 
percentages of the CD24HiCD38Hi Breg subset, which were significantly higher 
(p<0.05) in the postpartum period compared with the 3rd trimester, the day of 
delivery, and in non-pregnant women. 
Similarly to Breg cells, the absolute counts of all Treg subsets were significantly 
higher (p<0.05) in the postpartum period compared with the 3rd trimester and the day 
of delivery. In addition, intracellular expression of Foxp3 in the CD4DimCD25Hi Treg 
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subset significantly decreased (p<0.001) in the 3rd trimester of pregnancy and on the 
day of delivery compared with non-pregnant women; they also significantly 
increased (p<0.001) during the postpartum period compared with the 3rd trimester 
and on the day of delivery. 
Finally, the absolute counts and percentages of circulating Breg and Treg subsets 
were not significantly different between women who had elective cesareans (no 
labor) and those who had spontaneous vaginal deliveries (after labor). Nevertheless, 
the absolute counts of B cells and of NKT-like cells were significantly lower 
(p<0.05) in the peripheral blood of women who had vaginal deliveries. 
These findings indicated that the peripheral blood B cell and T cell 
compartments undergo quantitative changes from normal late pregnancy to the 
postpartum period. In particular, the results presented in this thesis suggest that 
circulating Breg and Treg subsets increase during the postpartum period, despite 
their well-known involvement in early pregnancy. In addition, labor does not seem to 
have a major impact on maternal peripheral blood T cell subsets and on Breg and 
Treg subsets. Therefore, these findings may improve our understanding of 
immunomodulation during human pregnancy and provide some evidence for the 
development of new strategies to diagnose and treat pregnancy-associated 
disturbances. These investigations may also contribute to the study of the 
mechanisms of maternal responses to vaccination and infection. 
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1 The Immune System 
The immune system is a host defense system comprising a network of molecules, 
cells, tissues and organs that protect the body against viruses, bacteria and other 
toxins. It can be divided into innate (a non-specific reaction to foreign antigens) and 
adaptive (to specific antigens) compartments (Figure 1).1 
Figure 1. Components of the immune system, innate and adaptive compartments, 
and various immune cells involved in defense. Adapted from Nouroz et al., 2016.1 
 
1.1 Innate Immune System 
The innate immune system is a first line of defense because it acts against 
invaders that cross physical barriers such as the skin and mucosa. The innate immune 
response consists of various phagocytes such as macrophages, neutrophils, natural 
killer (NK) cells, dendritic cells (DC), basophils and eosinophils.1,2 NK cells are 
involved in the destruction of tumor and virus-infected cells, while DCs, 
macrophages, basophils, eosinophils and neutrophils facilitate the inflammatory 
response, which is immediate but has a short duration. The innate immune response 
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requires no special preparation to act against pathogens and consists of chemical, 
mechanical, microbiological and cellular defense systems.3 
1.2 Adaptive Immune System 
The adaptive immune response is activated by the innate immune response 
through specific signals. There are two types of adaptive immune responses: humoral 
immunity, which is mediated by antibodies produced by B cells, and cell-mediated 
immunity, which is mediated by T cells. 
1.2.1 B cells 
B cells are lymphocytes that function in the humoral immunity component of the 
adaptive immune system by secreting antibodies with a vast range of antigen 
specificity.4-6 B cells also secrete cytokines and can act as antigen-presenting cells to 
activate T cells.7 B cells are also involved in the development of autoimmune 
diseases, partly through their ability to produce pathogenic autoantibodies.7 
In the current model of human peripheral B cell development, B cells leave the 
bone marrow and enter the circulation as immature transitional B cells (still unable to 
respond to antigen), which later mature into naïve B cells that are fully mature but 
have not encountered an antigen.6 Finally, when naïve B cells encounter their 
cognate antigens in secondary lymphoid organs such as the spleen, lymph nodes, and 
Peyer’s patches, these cells become activated and mature into memory B cells (which 
have encountered antigen and can survive for extended periods) and plasma cells 
(which produce soluble antibodies) (Figure 2). Subsequent exposure to the same 
antigen will activate memory B cells and trigger a larger and more rapid antibody 
response.6,8 
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Figure 2. B cell development and differentiation from hematopoietic stem cells to 
plasma cells. BCR, B cell receptor; BM, bone marrow; GC, germinal center; MALT, mucosa-
associated lymphoid tissue; sIg, surface Immunoglobulin; Spl, Spleen. Adapted from Tangye, 2011.9 
 
1.2.1.1 B cell classification systems 
B cell subsets of different maturational stages, from transitional to memory B 
cells, have been identified in peripheral blood using the mature B (Bm)1-Bm5 
classification system. This classification system has been shown to be effective for 
the identification of alterations in the proportions of peripheral blood B cell subsets 
in patients with autoimmune diseases (e.g., Lupus or Sjögren’s syndrome)10-12 and in 
those undergoing therapy (e.g., with biological agents), by assessing the depletion 
and repopulation of B cells.13 Recently, highly successful new therapeutic 
approaches based on changes in B cell subsets, such as depletion, have been highly 
successful for the treatment of a variety of leukemic and autoimmune diseases.14 
The Bm1-5 classification system used to identify the development of mature B 
cells by flow cytometry is based on the expression of IgD and CD38 phenotypic 
markers. According to this system, cells are characterized as transitional B cells 
(Bm2’: IgD+CD38Hi), naïve B cells (Bm2: IgD+CD38+), unswitched memory B cells 
(Bm1: IgD+CD38−), and switched memory B cells (Bm5: IgD−CD38+/−), which are 
subsequently divided into post-germinal memory B cells (early Bm5: IgD−CD38+) 
and resting memory (late Bm5: IgD−CD38−) B cells, and plasmablasts (Bm3 + Bm4: 
IgD−CD38Hi).10-12,15 However, this division is arbitrary and suggests a chronological 
relationship that has never been properly validated.10-12 
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The different maturational B cells subsets also can be identified in peripheral 
blood using another classification system centered on the expression of IgD and 
CD27.16 This classification is based on the concept that CD27 is a universal marker 
of the human memory B cells and allows the distinction between memory cells 
(CD27+) and the naïve B cells (IgD+CD27−). Memory B cells are then divided into 
switched memory (IgD−CD27+) and unswitched memory/marginal zone-like 
(IgD+CD27+) B cell subsets. Yet another subset of B cells are termed double-
negative memory cells (IgD−CD27−).17 
None of these two classification systems is complete and definitive (Figure 3) 
because the Bm1 compartment includes an important proportion (60%) of the 
memory B IgD+CD27+ subset, compared with 10% of the Bm2 compartment, which 
contains the essential pool of naïve B cells; the Bm2’ compartment corresponds to 
the transitional B cells CD24HiCD38Hi; and the IgD−CD27− B cell subset includes a 
population of CD27− memory B cells that are late Bm5 B cells.16,17 
 
 
Figure 3. Bm1-5 and IgD/CD27 classification systems of peripheral blood mature B 
cell subsets according to their differential expression of IgD/CD38 and IgD/CD27. 
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1.2.2 Regulatory B cells 
In recent studies,15,18 B lymphocyte functions have been reconsidered, and it is 
now accepted that these cells play much more diverse functions than antibody 
production alone. In addition to their humoral activity, specific subsets of B cells 
have regulatory functions (regulatory B cell, Breg), although this notion remains 
controversial. They can down regulate cellular immune responses and inhibit 
excessive tissue-specific inflammation. Bhan’s group first introduced the term 
“Bregs” based on evidence obtained in chronic colitis in 1997.19 
Breg cells have been thoroughly investigated during the last decade, mostly in 
studies involving murine models of chronic inflammation and autoimmune 
diseases.20 The presence of Breg cells in humans was later confirmed in other studies 
using in vitro models.21,22 
According to recent studies, Breg can inhibit pro-inflammatory responses by 
secreting the anti-inflammatory cytokine IL-10, one of the most important anti-
inflammatory cytokines capable of down regulating inflammation, avoiding an 
exacerbated inflammatory response.18,23 Breg cells were first reported to be IL-10-
producing B cells in mice and termed B10 cells.23 Hence, most of the work 
investigating Breg has focused on IL-10-producing B cells. However, B cells can 
exert regulatory functions independently of IL-10 production.24 Breg can regulate 
distinct profiles of inflammation, including T helper (Th) type 1 (Th1), Th type 2 
(Th2), and Th type 17 (Th17) cells (Figure 4).24 There is a growing body of evidence 
demonstrating that Breg cells are key players in different conditions, such as 
rheumatoid arthritis, autoimmune diabetes, autoimmune encephalomyelitis and 
lupus.25 
Regulatory functions have been attributed to different B cell subsets, and despite 
some controversy over this issue, some progress has been achieved in the 
characterization of Breg.26 The inability to identify a Breg-specific transcription 
factor, together with the phenotypic heterogeneity of Breg, supports the idea that 
Breg are not lineage-specific and that they may expand in response to inflammation 
when immunosuppression is necessary.27 It remains unclear whether the B cell 
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regulatory function is a specific role of a particular B cell subset or whether it is a 
reflection of their stage of maturation. 
Transitional B cells represent an essential developmental stage of B cell 
maturation,20 and the discovery of Breg has generated interest in their potential 
relationship with transitional B cells because of their phenotypic and functional 
similarities. Although almost all human B cells have the ability to produce IL-10, 
there is evidence that Breg cells are the most effective IL-10-producing B cells and 
consistently found within the CD24HiCD27+ and CD24HiCD38Hi cell populations, 
which are similar to CD24HiCD38Hi transitional B cells.12,18,23 Furthermore, links 
between the expansion of CD24HiCD38Hi transitional B cells and immune regulation 
were noted in the favorable clinical outcomes of patients with inflammatory and 
autoimmune diseases (e.g., more prolonged clinical responses).28 
However, the biology of transitional B cells in humans remains controversial. A 
recent study reported a new developmental pathway for human transitional B cell 
maturation.29 Simon et al. demonstrated that the transitional B cell subsets identified 
within CD24HiCD38Hi cells display differential regulatory abilities. This study 
revealed that CD27+ transitional B cells suppress the production of pro-inflammatory 
cytokines and have the capacity to produce high levels of IL-10. Although the 
capacity to produce IL-10 is frequently used as a marker for human Bregs, it was 
demonstrated that this property is not restricted to a specific B cell subset. Indeed, 
IL-10 was shown to be produced by transitional B cell subsets within the 
CD24HiCD27+ cells. Therefore, immune regulation by B cells might not be confined 
to a specific B cell subset and does not occur in a functionally restricted manner.29 
Instead, different B cell subsets seem to have different regulatory properties that are 
influenced by their microenvironment. Nevertheless, Simon et al. provides primary 
evidence that transitional B cells are not a homogeneous Breg cell population but 
rather represent a complex combination of subsets from which different Breg cells 
arise. 
Moreover, beyond the IL-10-mediated suppressive effects, strong evidence 
supports the dependence of the immunosuppressive effects of Breg cells on 
interactions with other immune cells and other regulatory cell lineages. For example, 
the maturation and function of human dendritic cells are regulated by B 
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lymphocytes.22 Moreover, B cells require signals from T cells to induce B cell 
regulatory functions, which in turn suppress T cell proliferative responses.30 
 
Figure 4. Positive (A) and negative (B) regulatory role of B cells. 
DC, dendritic cell; GC, germinal center; G-CSF, granulocyte-colony stimulation factor; GM-CSF, 
granulocyte-macrophage colony-stimulation factor; IFN, interferon; IL, interleukin; Mφ, macrophage; 
NK, natural killer; PC, plasma cell; TGF, transforming growth factor; Th, T helper cell; Tr1, type 1 
regulatory T cell Foxp3-; Treg, regulatory T cell. Adapted from Bao & Cao, 2014.31 
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1.2.3 T cells 
Following their development in the thymus, T cells are considered to be naïve 
until they first encounter a cognate peptide antigen. This encounter takes place in the 
secondary lymphoid organs and entails interactions with dendritic cells that present 
the cognate antigen on their cell surface in association with major histocompatibility 
complex (MHC) molecules. For CD4+ T cells, T cell receptor (TCR) signaling is 
stimulated upon engagement of peptide antigen:MHC class II complexes; for CD8+ T 
cells, T cell receptor signaling is stimulated upon engagement of peptide 
antigen:MHC class I complexes. If dendritic cells also supply sufficient co-
stimulation, the responding T cell suffers clonal expansion and then differentiates 
into one of the several T cell subsets, as specified by the set of cytokines encountered 
during antigen exposure (Figure 5). These subsets are Th1, Th2, Th17, effector CD4+ 
T cells, regulatory CD4+ T (Treg) cells or even cytotoxic T lymphocytes, which are 
usually effector CD8+ T cells. Once activated, an effector T cell exits the secondary 
lymphoid organs and then homes via the blood to the peripheral tissues.32 The T cells 
subsets are defined by the set of transcription factors they express to maintain their 
differentiated state, as well as by the set of cytokines they produce, which mediate 
their effector responses.33-35 
 
Figure 5. Naïve T cell differentiation into Th1, Th2 or Th17 cells, and the respective 
cytokine profiles. DC, dendritic cell; IL, interleukin; IFN, interferon; TGF, transforming growth 
factor; Th, T helper cell; TNF, tumor necrosis factor; TReg, regulatory T cell. Adapted from Zen et 
al., 2010.36 
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1.2.4 Regulatory T cells 
Regulatory T cells can be classified into thymic (naturally occurring) and 
extrathymic (inducible or peripheral) Treg cells.37 The former differentiate in the 
thymus, similar to other T cells, and constitute the majority of Treg, which are 
capable of recognizing both self and non-self-antigen.38 The latter are a smaller 
population of Treg, which differentiate from peripheral T cells (naïve CD4+ T cells) 
or are produced by ex vivo stimulation with antigens in the presence of TGFβ and 
retinoic acid.38 The thymic-derived Treg are predominantly associated with the 
preservation of immune homeostasis and the prevention of autoimmunity, and they 
are not involved in maternal-fetal tolerance. Extrathymic Treg cells have been shown 
to play an important role in establishing tolerance at interfaces, such as the mucosal 
surfaces of the lung and gut, where the immune system comes into contact with the 
exterior and is chronically exposed to allergens and other foreign antigens; and 
maintaining an allogeneic pregnancy by inducing maternal-fetal tolerance (Figure 
6).37 
 
Figure 6. Role of peripheral regulatory T cells in maternal-fetal immunotolerance. 
The thymus exports naïve T cells (not expressing the transcription factor Foxp3, Foxp3-) and thymus-
generated Tregs (tTreg). Peripheral Tregs (pTreg) differentiate from peripheral Foxp3- T cells in 
response to TGFβ. Adapted from Gobert & Lafaille, 2012.37 
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As mentioned above, Treg are a specialized CD4+ T cell subpopulation that is 
involved in the establishment of immune tolerance against self-antigens and antigens 
encountered in the foreign graft,2,39 because they are potent suppressors of 
inflammatory immune responses. Additionally, Treg prevent maternal T cell 
activation against fetal cells, and this protection of the fetus from the maternal 
immune system has been widely reported in both mice and humans.40-42 
Although numerous Treg-specific markers have been proposed for mice and 
humans, expression of the transcription factor Forkhead box p3 (Foxp3) is still the 
most consistent marker, and this protein seems to be essential for the development 
and maintenance of Treg and for the function of these immunosuppressive cells.43,44 
The Treg population has been defined as CD4+CD25HiCD127-/dimFoxp3+, although 
the literature varies when considering markers for the exact phenotype of a Treg 
population.45 In humans, detection of the CD4DimCD25Hi, CD4+CD25HiFoxp3+ and 
CD4+CD25HiCD127-/dim T cell populations remains amongst the most common 
analytical strategies used to identify Treg subsets.42,46-48 
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2 Immunological Aspects of Pregnancy 
Pregnancy in humans is accompanied by profound changes and adaptations in 
both endocrine and immune systems. These adaptations are necessary for the 
maternal immune system to accept and tolerate a semi-allogeneic fetus expressing 
foreign antigens.49 However, in some cases, these changes may influence the course 
of pre-existing pathologies, as observed in the case of autoimmune diseases.50 
Simultaneously, mother and fetus must be properly protected against potential 
infections.51,52 To accomplish this goal, the immune machinery must be strictly 
regulated during the different stages of pregnancy.53 As described previously, this 
regulation is considered to be promoted by several types of immune cells and by an 
array of anti-inflammatory and pro-inflammatory cytokines.2,3 In addition, abundant 
evidence has highlighted the role of female sex hormones in shaping the immune 
system toward the transient state of tolerance necessary for the maintenance of 
pregnancy, in addition to their accepted functions in coordinating and controlling the 
anatomical modifications associated with pregnancy.54 Our knowledge of the unique 
immunological relationship between the mother and the fetus is now substantially 
advanced, but there are still missing pieces of the puzzle. 
In general terms, discussions concerning the nature of the immune response to 
pregnancy have centered on the extent to which the innate and adaptive immune 
compartments, and their component elements of the immune response, are essential 
participants in the process of maternal immune suppression or tolerance of the 
embryo/fetus.2 For example, macrophages, DCs, and NK cells, which are central 
cellular components of the innate immune system, have been described to be 
important in pregnancy.55 However, the participation of components of the adaptive 
immune system is more difficult to ascertain because it is a more advanced system of 
defense involving a repertory of lymphocytes that can express a wide range of 
receptor systems against specific foreign entities. 
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2.1 Mechanisms of Maternal-Fetal Immunotolerance 
2.1.1 Maternal-Fetal Immunotolerance Initiated by the Trophoblast 
Much of what is known about maternal-fetal immunology has been derived from 
research designed to explain how the fetal and placental semi-allograft avoids 
immunological attack by the mother. There are numerous mechanisms underlying 
immune tolerance in the placenta, and many of these depend on the interaction 
between maternal and fetal cells (Table 1). 
First, during the immunosuppression mechanism that occurs via paracrine 
signaling, macrophages from the decidua up-regulate indoleamine 2,3-dioxygenase 
(IDO), which metabolizes the amino acid tryptophan into L-kynurenine. This 
tryptophan depletion at the maternal-fetal interface prevents effector T cell and NK 
cell activation and promotes Treg cell activation.56,57  
Immunosuppression may also act via exosomes produced by the 
syncytiotrophoblast carrier molecules, namely Fas ligand (FasL), whereas the active 
form has the capacity to induce apoptosis in activated immune cells.58 Trophoblast 
cells induce apoptosis of activated immune cells through the expression of FasL on 
its surface, and this FasL expression is supported by locally produced anti-
inflammatory cytokines.58 The Fas/Fas ligand system is an excellent example of a 
mechanism that supports life and of the function of the reproductive tissues, by 
enabling death via apoptosis. 
In another mechanism, the expression of MHC molecules on trophoblast cells is 
repressed (the trophoblast does not present alloantigens) as a strategy to avoid 
recognition and destruction by maternal immune cells.56 As a result, peripheral blood 
lymphocytes from pregnant women demonstrate a reduced capacity to develop into 
effector cytotoxic T lymphocytes. 
In the mechanism of immune evasion, expression of MHC proteins at the 
maternal–fetal interface is strictly regulated during pregnancy,56 and the human 
leukocyte antigens (HLAs) that are expressed in fetal membranes are tolerogenic 
rather than immunogenic. MHC class I genes are subdivided into classes Ia and Ib. 
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MHC class Ia is further subdivided into HLA-A, B, and C, and class Ib is subdivided 
into HLA-E, F, and G. HLA class II (HLA-D) genes are not translated in human 
trophoblast cells. The lack of MHC class II molecules protects the fetus from the 
presentation of fetal antigens to maternal immune cells. Human trophoblast cells 
express one MHC class Ia (HLA-C) and all MHC class Ib molecules. In the human 
placenta, fetal trophoblast cells lack expression of MHC class Ia (i.e., HLA-A and B) 
molecules, which are responsible for the rejection of allografts in humans. In normal 
pregnancies, decidual T cells recognize fetal HLA-C at the maternal-fetal interface 
but are prevented from inducing a destructive immune response.56 
HLA-G seems to be an essential immunosuppressive factor during pregnancy 
and has been identified as a naturally occurring tolerance-inducing molecule.59 HLA-
G was originally discovered on the extravillous cytotrophoblast at the maternal-fetal 
interface, and its expression in the amniotic membrane may influence the maternal 
immune system during the inhibition of CD8+ cytotoxic T cell and peripheral and 
decidual NK cell activities, the allogeneic proliferative response of CD4+ T cells and 
cell cycle progression of alloreactive T cells.59 
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Table 1. Mechanisms of Immunological Tolerance Initiated by the Trophoblast 
Mechanism Function 
Immunosuppression 
via paracrine 
signaling 
• IDO secretion: inhibits T cell responses via tryptophan 
depletion 
• VIP secretion: promotes differentiation of regulatory T cells 
• Soluble HLA-G secretion: protects against NK-cell-mediated 
cytotoxicity 
Cell-cell interaction • FasL expression: induces apoptosis upon ligation of Fas 
expressed on activated leukocytes 
Induction of maternal 
tolerance 
• Trophoblast shedding: exposes the maternal circulation to 
paternal antigens shed from trophoblast cells 
• Fetal microchimerism: exposes the maternal circulation to 
paternal antigens by directing the trafficking of fetal cells 
Immune evasion • Lack of surface MHC II: induces escape recognition by CD4+ 
helper T cells 
• Lack of HLA-A and HLA-B: induces escape recognition by 
CD8+ cytotoxic T cells 
• Expression of HLA-C, HLA-E and HLA-G: decreases 
recognition by the immune system because these MHC 
isotypes exhibit low to undetectable levels of polymorphism 
Note: FasL, Fas ligand; HLA, human leukocyte antigen; IDO, indoleamine 2,3-dioxygenase; MHC, 
major histocompatibility complex; VIP, vasoactive intestinal peptide. 
Adapted from Hsiao & Patterson, 2012.60 
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2.1.2 Maternal Innate Immune Response During Pregnancy 
Implantation requires a receptive endometrium, a so-called healthy uterine 
“milieu” that allows invasion of the blastocyst and rapid growth of the placenta while 
supporting the transformation of uterine into decidual cells.2 This process is 
facilitated by hormonal changes and, importantly, by the immune cell populations 
and their cytokines.61 
The immune cells that are relevant for implantation are already present in the 
uterus before pregnancy. The most studied uterine immune cells are the uterine NK 
(uNK) cells, comprising 70% of the human decidual leukocytes,62 uterine dendritic 
cells (uDCs),63-66 uterine mast cells (uMCs),67,68 and uterine macrophages 
(comprising about 20% of the human decidual leukocytes),57,69 which are crucial for 
modulating trophoblast function (Table 2). 
The specific immune cells that are present in the uterus fluctuate in number, 
potentially due to a hormonal influence.61 This phenomenon applies to uNK cells and 
macrophages, but other cells are likely to be attracted from the periphery to the 
uterus in response to the hormonal changes in early pregnancy, as shown for uMCs 
and macrophages.61 For uDCs, it is still uncertain whether they live in the uterus or 
are attracted by pregnancy hormones, or both.2 
Additionally, to act as the first line of defense, the cells of the innate immune 
system that are present in the uterus acquire an additional role. They dynamically 
contribute to the establishment of pregnancy either by remodeling the tissue or by 
releasing angiogenic factors that contribute to spiral artery remodeling.2 
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Table 2. Function of Uterine Innate Immune Cells During Pregnancy 
Cell type Role Reference 
Natural killer 
cells 
Promote decidual angiogenesis and spiral 
artery remodeling, important for 
implantation. 
Ratsep et al., 201562 
Dendritic cells Promote T helper type 2 cell response, 
preparation of the uterus for implantation, 
early antigen presentation to T cells and 
regulatory T cells; mediators of 
communication between the trophoblast 
and regulatory T cells. 
Bachy et al., 200863, 
Plaks et al., 200864, 
Zenclussen et al., 201065, 
Du et al., 201466 
Mast cells Promote angiogenesis at the maternal—
fetal interface; modulate spiral artery 
remodeling; support implantation and fetal 
growth. 
Woidacki et al., 201367, 
Schmerse et al., 201468 
Macrophages Protect the growing fetus from 
microorganisms, aid placental development 
by promoting trophoblast invasion and 
spiral artery remodeling, and contribute to 
the parturition process. 
Fest et al., 200769, 
Tang et al., 201557 
Neutrophils Support angiogenesis. Amsalem et al., 201470 
 
 
2.1.3 Maternal Adaptive Immune Response During Pregnancy 
After pregnancy is established, multiple immune system mechanisms must 
coexist to guarantee maternal-fetal immunotolerance (Table 3). This state of 
immunological tolerance may influence the course of pre-existing pathologies (e.g., 
autoimmune diseases)50 and may also increase fetal-maternal susceptibility to 
infections.71 Indeed, a decrease in B cells function with a loss of responsiveness to 
mitogens and infectious agents during the course of a normal human pregnancy has 
been reported.72 
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B cells play a role in pregnancy because of their humoral activity.73 The 
generation of asymmetric antibodies occurs in normal pregnancy, protecting the fetus 
and placental antigens against maternally derived symmetric (antipaternal) antibodies 
at the maternal-fetal interface.74 Additionally, these asymmetric antibodies prevent 
immunological attack by maternal NK cells and cytotoxic lymphocytes. Their 
secretion seems to be partially hormone-regulated, and their absence has been 
associated with pregnancy failure.75 
Beyond the commonly recognized role of B lymphocytes in antibody 
production, B cells can also act as antigen-presenting cells to induce T cell immune 
responses. However, B cell functions can be regulated by cytokines. For example, B 
cell-activating factor (BAFF), a member of the TNF family of cytokines that is 
produced by both innate immune cells and non-hematopoietic cells, is a key regulator 
of B cell maturation and function. Signals induced when BAFF interact with its main 
receptor on B cells are pivotal for the survival and differentiation of immature 
transitional B cells into mature naïve cells.76 Circulating BAFF levels have been 
positively associated with the proportions of memory B cells, and inversely related to 
the proportions of immature/naive B.77 Excessive BAFF-mediated survival of 
peripheral immature B cells contributes to the emergence and maturation of 
autoreactive B cells,76 and high levels of BAFF are associated with autoimmune 
disorders.78 
The physiological and pathophysiological function of BAFF in pregnancy is 
uncertain, and it is not known whether BAFF plays any role in mediating the immune 
bond between mother and infant during the postpartum period.79 Still, there is 
accumulating evidence that BAFF could be a suitable candidate for the role of a 
pivotal autocrine and paracrine regulator of immune processes in the human placenta 
and breast, leading to specific regulatory effects on placental cell viability and 
differentiation.80 
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Table 3. Function of Adaptive Immune Cells During Pregnancy 
Cell type Role Reference 
B cells Protection of the fetus against maternally 
derived symmetric antibodies; fight danger 
signals at the maternal-fetal interface. 
Zenclussen et al., 200174 
Regulatory B cells Involved in maternal-fetal immune 
tolerance through IL-10; play a role in 
protecting pregnancy from the adverse 
effects of inflammatory stress during 
gestation; positively influence pregnancy 
by blocking Th1 cell immune responses. 
Zenclussen et al., 200174; 
Fettke et al., 201481; 
Muzzio et al., 201482 
T cells Protection of the placenta from immune 
rejection and facilitation of embryo 
implantation. 
Nancy & Erlebacher, 201432 
Regulatory T cells Contribution to an adequate uterine 
environment that guarantees implantation; 
early tolerance of paternal antigens 
expressed by the fetus. 
Guerin et al., 201183; 
Teles at al., 201384 
 
 
2.1.3.1 B cell subsets and regulatory B cells in pregnancy 
Numerous studies,85-95 both prospective and cross-sectional, have reported data 
for circulating B cells during normal human pregnancy, among which the majority 
have described a lower total number or frequency compared with the levels in the 
postpartum period or in healthy non-pregnant women (Table 4). Most studies87-93,95 
have only investigated total B cells, as defined by the expression of CD20 or CD19, 
and older studies85,86,94 used either the expression of Ia (human leucocyte antigen – 
antigen D related complex, HLA-DR) or surface immunoglobulin to identify B cells. 
A few studies88-91 have reported the frequency of B cell subsets expressing CD5, 
with the majority describing a lower frequency or lower total numbers of this subset 
during pregnancy, at delivery, or early in the postpartum period. One study88 reported 
lower CD21 and CD23 frequencies at delivery. However, peripheral blood B cells 
have not been characterized in human pregnancy while considering the different 
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maturational stages, from transitional to memory B cells (using CD38 and 
immunoglobulin IgD as differentiation markers). 
 
Table 4. Peripheral Blood B Cell Populations During Human Pregnancy and the 
Postpartum Period 
B cell marker Variation in B cell numbers (period) N Reference 
Ig+ decrease in % (pregnancy) 32 Christiansen et al., 197694 
Ia+ no change in % and decrease in absolute 
numbers (pregnancy) 
5 Moore et al., 198385 
Ig+ decrease both in % and in absolute 
numbers (pregnancy) 
77 Valdimarsson et al., 198386 
CD20+ no change in % and decrease in absolute 
numbers (pregnancy); 
increase in % (postpartum) 
94 Iwatani et al., 198887 
CD20+CD5+ 
CD20+CD19+ 
CD20+CD21+ 
CD20+CD23+ 
decrease in absolute number (postpartum) 23 Delgado et al., 199488 
CD20+CD5+ decrease in % (pregnancy); 
increase in % (postpartum) 
18 Bhat et al., 199589 
CD19+ 
CD19+CD5+ 
decrease in absolute numbers (pregnancy); 
increase in absolute numbers (postpartum) 
5 Matthiesen et al., 199690 
CD19+ 
CD19+CD5+ 
decrease in absolute numbers (pregnancy); 
increase in absolute numbers (postpartum) 
106 Watanabe et al., 199791 
CD19+ decrease in % (pregnancy) 92 Kuhnert et al., 199892 
CD19+ decrease both in % and in absolute 
numbers (pregnancy) 
34 Mahmoud et al., 200193 
CD19+ decrease in absolute numbers (pregnancy); 
increase in absolute numbers (postpartum) 
50 Kraus et al., 201295 
Note. N, number of healthy pregnant women. 
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There is a growing body of evidence demonstrating that Breg are key players in 
different situations in which the immune system is hyperactivated.24,96 Breg counts 
increase in the first trimester of pregnancy, suppressing the unwanted immune 
responses of maternal effector T cells and protecting against pregnancy loss.15 These 
findings suggest that B cells with regulatory functions may be important for a better 
understanding of the mechanisms characterizing pregnancy and delivery. 
While the phenotype and function of regulatory T cells have been extensively 
studied,97 additional studies are needed to investigate the mechanisms underlying the 
activation and expansion of Breg and other B cell subsets during pregnancy. 
 
2.1.3.2 T cell subsets and regulatory T cells in pregnancy 
Physiological pregnancy has been compared to a state of quiescent systemic 
inflammation, and parturition has been compared to an immunological reaction that 
results in the recruitment of immune cells to the systemic circulation and the 
maternal-fetal interface.98 This entire process may have an effect on the maturation 
and activation profiles of T cells in the peripheral blood of pregnant women.99,100 
T cells are abundant in the human decidua, comprising approximately 10-20% of 
decidual leukocytes,49 of which 30% to 45% are CD4+ T cells and 45% to 75% are 
CD8+ T cells.32 The main function of T cells in the decidua, particularly of the CD4+ 
Treg cells, is generally thought to be the promotion of fetal tolerance. 
During a successful pregnancy, the normal profile is Th2-type immunity, which 
is more accentuated at the maternal-fetal interface.49 In addition, Th2 cytokines down 
regulate Th1-type reactivity. Labor is often linked to a pro-inflammatory state with 
reversal back to a Th1 rather than a Th2 profile. Currently, to explain this 
immunotolerance in pregnancy, the Th1/Th2 paradigm has been expanded into the 
Th1/Th2/Th17/Treg paradigm. In this new paradigm, Th17 cells, which produce IL-
17, are mediators of inflammation along with Th1 cells, while Treg cells, which are 
potent suppressors of inflammatory immune responses, may be important for the 
induction of antigen-specific tolerance.101 
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Th17 cells are present in decidua and are increased in the peripheral blood of 
normal pregnancies, playing a role in controlling the maternal-fetal relationship and 
development of the placenta.102 Practically all effector T cells generated in response 
to an immunogenic antigen undergo apoptosis following the completion of antigen 
clearance. Still, a few of these antigen-experienced cells survive and differentiate 
into memory T cells, which are capable of establishing rapid responses after a second 
contact with the antigen;32 however, their role in pregnancy has not yet been 
investigated. 
Recent reports have suggested that another heterogeneous population of T cells 
might also have an important function in fetal-maternal immunological tolerance and 
in the regulation of the Th1/Th2 balance: the CD3+CD56+CD16+ natural killer T 
cells-like (NKT-like). This subset simultaneously expresses T cell and NK cell 
surface markers, and has been found in peripheral blood and in human decidua.103 
Nevertheless, published data regarding the role of circulating levels of NKT-like 
cells in embryo implantation have been contradictory.104,105 
Regarding T cells with regulatory functions, several studies have reported their 
expansion in the decidua of normal pregnant women. This expansion is most 
vigorous during early pregnancy and decreases as the end of term approaches, 
suggesting that the immune regulatory processes that occur at the maternal-fetal 
interface are dynamic and provide immune protection for the fetus.41 However, the 
current set of data does not determine whether Treg cells act locally within the 
uterus, systemically, or both.101 
Owing to the bidirectional cell trafficking between mother and fetus, antigen 
presentation and recognition can occur in any compartment of the maternal immune 
system.106 Given the well-known immunosuppressive functions of Treg cells, a new 
model suggests a hypothetical scenario in which Treg cells expand within the 
decidua as a result of the presentation of placental antigens by decidual antigen-
presenting cells.107 This phenomenon occurs to limit effector T cell activity at the 
maternal-fetal interface to permit tolerance to the fetus and to prevent rejection via 
classical immune mechanisms. Paternal antigens are first encountered in the vaginal 
lumen, where maternal dendritic cells meet paternal antigens present in the seminal 
fluid. After this first step, dendritic cells take up paternal antigen and migrate to 
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lymph nodes draining in the uterus. DCs present paternal antigens to Treg cells, and 
Treg cell proliferate prior to the implantation. These paternal antigen-specific Treg 
cells migrate to the pregnant uterus (maternal-fetal interface) guided by chemokines 
and human chorionic gonadotropin (hCG), modulate the phenotype and function of 
immune cells and generate a friendly environment for embryo implantation.101,107 
Changes in Treg numbers during human pregnancy occur not only in the decidua 
but also in the maternal peripheral blood.108,109 Treg subsets in the peripheral blood 
have been explored in normal human pregnancy and during the postpartum period in 
numerous studies (Table 5); however, the results have been highly inconsistent, with 
some reports showing a decrease110 or an increase42,111-115 during the 1st trimester, a 
decrease110,116 or an increase42,112,114,115,117 during the 2nd trimester, or a 
decrease41,42,110,112-115 or an increase48,109,113,117 during the 3rd trimester; others have 
shown either no changes113 or a decline115,117 during labor and a decrease42,112,115 or 
an increase118 in the postpartum period. These discrepancies can be attributed to 
differences in study design because some studies did not include the postpartum 
period,41,110,113,114,116,117 and other studies did not obtain samples from some women 
at all time points.42,110,112-115,118 Distinct reports of Treg patterns may also be 
attributed to differences in sample size, laboratory techniques, or the use of different 
and sometimes non-specific markers to identify Treg subsets. 
While the phenotype and function of regulatory T cells have been extensively 
examined,97 additional studies are needed to investigate the mechanisms underlying 
the activation and expansion of Breg and other B cell subsets in human pregnancy. 
  
General Introduction 
51 
Table 5. Peripheral Blood Regulatory T Cell Populations During Human Pregnancy 
and the Postpartum Period 
Regulatory T cell 
marker 
Variation in Treg numbers N Reference 
1st T 2nd T 3rd T L PP 
CD4+CD25+ 
CD4+CD25+CTLA-4i+ 
peak ä æ   7 Heikkinen et al., 200441 
CD4+CD25+ ä peak æ  æ 63 Somerset et al., 2004112 
CD4+CD25bright ä     19 Sasaki et al., 2004111 
CD4+CD25bright   ä   40 Sasaki et al., 2007109 
CD4+CD25+Foxp3+  æ æ   188 Steinborn et al., 2008114 
CD4+CD25bright peak ä ä   32 Seol et al., 2008113 
CD4+CD25high 
CD4+CD127lowCD25+ 
CD4+Foxp3+ 
  ä   47 Santner-Nanan et al., 200948 
CD4dimCD25highFoxp3+  ä    38 Mjosberg et al., 2009116 
CD4+CD25+Foxp3+ ä peak æ æ æ 139 Xiong et al., 2010115 
CD4+CD25+C127low+/-
Foxp3+HLA-DR+ 
æ æ æ   82 Kisielewicz et al., 2010110 
CD4+CD25+Foxp3+CD127−     ä 208 Wegienka et al., 2011118 
CD4+CD25+ 
CD4+CD25+CD127− 
ä ä æ  æ 90 Xiong et al., 201342 
CD4+CD25highCD127low 
Foxp3+ 
 ä ä æ  20 Areia et al., 2015119 
Note. Treg, regulatory T cell; T, trimester; L, labor; PP, postpartum; N, number of healthy pregnant 
women. ä, increase; æ, decrease. 
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2.2 Endocrine and Immune System Interaction During Pregnancy 
Pregnancy is associated with changes in the concentrations of several hormones, 
including estradiol, estriol, progesterone, human chorionic gonadotropin, 
corticosteroids, and prolactin. These hormonal changes contribute to the 
immunological shifts that occur during pregnancy, and there is increasing evidence 
that immune-endocrine interactions generate a complex network of immune 
regulation that ensures fetal survival within the maternal uterus (Figure 7).120,121  
Human chorionic gonadotropin initially maintains progesterone levels by 
inducing its production by the corpus luteum. After the luteal-placental shift, the 
placenta (trophoblast cells) takes over progesterone production, which is then 
secreted into the maternal circulation. The placenta also synthesizes estrogens from 
fetal and maternal precursors and secretes them into the fetal and maternal 
circulations. These pregnancy hormones are critically involved in the successful 
establishment, maintenance, and termination of pregnancy.61 They suppress 
damaging maternal alloresponses while promoting tolerance pathways (reduction of 
the antigen-presenting capacity of dendritic cells, monocytes, and macrophages, and 
blockage of NK cells, T and B cells). Pregnancy hormones also promote the 
proliferation of pregnancy-supporting uterine NK cells, retention of tolerogenic DCs, 
and efficient induction of Treg cells. Moreover, they are involved in the recruitment 
of mast cells and Treg cells into the maternal-fetal interface, contributing to a local 
accumulation of pregnancy-protective cells.36,61 
Figure 7. Pro-inflammatory and anti-inflammatory responses during pregnancy. 
Adapted from Robinson & Klein, 2012.120 
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Progesterone exerts its immune regulatory functions via mediators such as 
progesterone-induced blocking factor (PIBF). PIBF has several anti-abortive effects 
in vivo and a pregnancy-protective role: it enhances asymmetric antibody production 
by B cells, causes a Th2/Th1 shift to increase the production of Th2 cytokines, and 
inhibits the cytotoxicity of NK cells.122 Recently, membrane progesterone receptors 
(e.g., mPRα) were found in human peripheral blood T lymphocytes,123 specifically in 
Tregs,119 suggesting that their levels change during preterm labor and that human 
labor may develop as a consequence of a decline in mPRα+ Treg cells. This decline 
reduces progesterone anti-inflammatory activity by permitting Treg cell 
inflammatory responses associated with cervical ripening, membrane rupture and 
uterine contractions.117,119 
During pregnancy, estrogens affects different immune cell populations (their 
numbers and functions) and thereby contributes to fetal tolerance. Estrogens enhance 
IL-10, IL-2, and IFN-γ production, and inhibit TNF-α secretion by peripheral blood 
mononuclear cells; stimulate antibody production by B cells, and decrease apoptosis 
of DC and macrophages.36 These effects are mediated via the binding of estrogens to 
its intracellular receptors, estrogen receptor alpha (ERα) and beta (ERβ), expressed 
in various lymphoid tissue cells as well as in lymphocytes, macrophages, and 
dendritic cells, which in turn modulate the expression of many genes.61 
The effects of pregnancy-related hormones on Treg expansion have been 
investigated. While one study in mice124 have shown that neither estrogen nor 
progesterone can stimulate Treg expansion, others125,126 have indicated the opposite, 
showing that estrogens expand the Treg compartment and increase Foxp3 expression. 
A recent study suggested that high estrogen levels might induce an increase in Treg 
in the peripheral blood, influencing immune functions in pregnant women.42 These 
results confirmed an important role of estrogen in immunomodulation during 
pregnancy. 
The maternal and fetal immune system activation that occurs with labor127-130 is 
a consequence not only of the increased production of cytokines in the uterine 
milieu,131 but also due the increase in cortisol levels in the maternal circulation and in 
the umbilical cord blood from neonates.132 In humans, circulating glucocorticoids 
increase as gestation progresses, peaking during labor.133 Although the precise 
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function of cortisol in pregnancy is not well defined, it is known that this stress 
hormone, with potent anti-inflammatory and immunosuppressive effects, inhibits the 
synthesis of pro-inflammatory molecules, including cytokines, suppresses pro-
inflammatory cytokine production by term human placental cells in vitro, and has the 
capacity to suppress both innate and adaptive immune responses.134,135 
 
2.3 Changes in Immune Responses and Pregnancy Complications 
Cells of the innate immune system are present in the uterus at fecundation, and 
their presence is fundamental for the initiation of tissue remodeling that ensures 
implantation and later to support the adaptation of the maternal spiral arteries. The 
presence of these essential immune cells and the influx of new ones at peri-
implantation dictate its success. In animal models, the specific depletion of 
macrophages, dendritic cells, and mast cells disrupts implantation.2 
The human maternal-fetal interface is normally colonized by a wide variety of 
bacteria, suggesting that effector T cells within the decidua have specificity for 
placental antigens and might have a positive function in controlling infection.32 This 
function is very finely adjusted so that the response is sufficient to prevent problems 
related to the progression to pregnancy, such as acute infectious chorioamnionitis, 
and it is not so robust that the attendant inflammation required to fight the infection 
can lead to pregnancy complications, such as preterm labor secondary to 
chorioamnionitis.32 The existence of intra-decidual mechanisms to limit maternal T 
cell responses against the placenta, which alter the dynamics of the decidual CD8+ T 
cell response by changing the CD8+ T cell repertoire and increasing the influx of 
CD8+ T cells to the decidual tissue, alter MHC expression profiles of infected 
trophoblast cells and increase the production of pro-inflammatory cytokines and 
chemokines. These processes might also explain why the decidua is susceptible to 
infection by certain organisms such as Listeria monocytogenes and 
cytomegalovirus.136 
From the adaptive immune system, regulatory T cells are critical for early 
pregnancy establishment. Their depletion before implantation negatively affects the 
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uterine environment, provoking inflammation and fibrosis in the uterus, which 
impedes implantation.84 Interestingly, primary unexplained infertile women have 
reduced expression of endometrial Foxp3, supporting the relevance of Treg for 
implantation.137  
A composed state of immune cell populations in the uterus during initial 
pregnancy is of importance not only for successful implantation but also for the 
quality of placentation. It is well-known that a deficient immune response at the 
onset of pregnancy can result in abnormal implantation and poor placentation, 
eventually ending in miscarriage, fetal growth restriction, or pre-eclampsia.2 
Traditionally, the state of immunological fetal tolerance has been explained by the 
predominantly Th2-type immunity found in normal pregnancies; in contrast, a 
predominantly Th1-type immunity was used to explain pathological pregnancies, 
such as those characterized by recurrent spontaneous abortion, intrauterine growth 
restriction, and pre-eclampsia.138-143  
A decline in maternal Treg populations could cause failure of immunological 
tolerance to the fetus and has been associated with obstetrical complications, such as 
miscarriage, pre-eclampsia, and preterm labor.109,115,143-146 Finally, disproportions 
between Th17 and Treg cells during the proliferative phase of the menstrual cycle 
has been recently considered as a cause for abortion in women with recurrent 
spontaneous abortion.147,148 
Modifications of the immune environment during pregnancy have systemic 
consequences that may modify the course of some diseases.84 The decrease in 
activity of pro-inflammatory cytokines and NK cells, inflammatory macrophages, 
and Th1 cells, together with the elevated Treg cell activity and production of anti-
inflammatory cytokines, decreases the severity of diseases caused by inflammatory 
responses (i.e., arthritis and multiple sclerosis) and increases the severity of diseases 
that are relieved by inflammatory responses (such as influenza and malaria) (Figure 
8).120 
Unlike the protective effect proposed for asymmetric antibodies, the production 
of natural autoantibodies facilitates pregnancy complications. In patients with 
autoimmune disorders, it is possible that B cells secrete more autoantibodies that 
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compromise the pregnancy outcome.73 In this regard, antiphospholipid antibodies 
have been associated with venous or arterial thrombosis and obstetric complications, 
such as recurrent miscarriage, fetal growth restriction, pre-eclampsia, placental 
abruption, premature delivery or fetal death.149 In pre-eclampsia, B cells can become 
autoreactive and secrete antibodies against angiotensin receptor 1.150 Emphasizing 
the idea of the involvement of B cells in the pathophysiology of pre-eclampsia, some 
authors have demonstrated that B cell depletion in a rat model of pre-eclampsia 
correlates with lower levels of antibodies against angiotensin receptor 1 and reduced 
symptoms of pre-eclampsia.151 
 
Figure 8. Immunological changes in pregnancy and outcome of diseases. 
Adapted from Robinson & Klein, 2012.120 
 
The mechanism responsible for the syndrome remains unknown, but pre-
eclampsia has the “fingerprints” of an immune response. It occurs mainly in first 
pregnancies, when the mother has had fewer opportunities to develop tolerance 
against paternal antigens, and inflammation is a major part of its pathogenesis. In 
2012, it was reported that memory-type fetal antigen-specific Treg cells are present 
in a second gestation and that these Treg cells induce fetal antigen-specific 
tolerance.152 This important finding explained the epidemiological paradigm in 
which the first conception and first pregnancy with a new partner or a long interval 
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between births are risk factors for pre-eclampsia.153 Consequently, the proper 
development of regulatory T cells is likely to play a role in preventing this disorder. 
Some authors have found that women with pre-eclampsia not only have a lower 
percentage of Treg cells but also a higher percentage of Th17 cells, as compared with 
normal pregnant women.48 Recent evidence has shown that the polymorphism Fas-
1377G>A in one of the most important apoptotic pathways, the Fas/FasL system, is 
associated with decreased Fas and FasL expression, a predominance of Th1 
immunity, inflammation and trophoblast damage, and an elevated risk of pre-
eclampsia.154 
Inflammation at the maternal-fetal interface is one of most well recognized 
causes of preterm birth. During labor, the maternal immune system is activated, 
resulting in increased absolute counts and percentages of peripheral blood 
leukocytes,128-130 mainly due to the increase in absolute counts and percentages of 
neutrophils and the decrease in absolute counts and percentages of peripheral blood 
lymphocytes.127 Therefore, excessive levels of pro-inflammatory cytokines or 
reduced levels of anti-inflammatory cytokines can explain the subsequent events 
leading to preterm birth. The number of Th17 cells is increased in the chorioamniotic 
membrane of cases of preterm delivery with chorioamnionitis.155 These findings 
suggest that Th17 cells promote inflammation at the maternal-fetal interface in 
preterm delivery. Recent data have revealed the presence of membrane progesterone 
receptors (mPRs) in human Treg cells, which may explain the actions of 
progesterone on preterm birth and strengthen the rational use of this hormone for this 
type of obstetric complication.117,119 
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General Objective 
The main goal of the present research was to characterize the populations of B 
cells and T cells, specifically their regulatory subsets, in the peripheral blood of 
healthy pregnant women from the 3rd trimester to the postpartum compared to non-
pregnant women. 
 
Specific Objectives 
In detail, the specific objectives were as follows: 
• Analyze the variation of the absolute counts and percentages of specific B 
cell subsets (maturational stages) and regulatory B cell subsets (defined as 
CD24HiCD27+, CD24HiCD38Hi and IL-10 producing B cells) in the peripheral 
blood of pregnant women, from late pregnancy to the postpartum  
(Chapter III); 
 
• Investigate the variation of the absolute counts and percentages of the 
regulatory T cell subsets (defined as CD4DimCD25Hi, CD4+CD25HiFoxp3+, 
and CD4+CD25HiCD127-/dim) in the peripheral blood of pregnant women, 
from late pregnancy to the postpartum (Chapter IV); 
 
• Assess the effect of labor on the absolute counts and percentages of T cell 
subsets (maturational and activation profiles), regulatory T cell subsets, and 
regulatory B cell subsets in the peripheral blood of healthy women on the day 
of delivery (Chapter V). 
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Abstract 
Regulatory T cells (Tregs) are critical immunomodulators during early 
pregnancy by preventing maternal T cell activation against fetal cells. However, how 
populations of maternal Tregs vary during and after pregnancy in humans is still 
unclear. Therefore, we investigated Treg subsets in the peripheral blood of pregnant 
women from late pregnancy through the postpartum period. To accomplish this, the 
following circulating Treg subsets were analyzed in 43 healthy pregnant women and 
35 non-pregnant women by flow cytometry during the 3rd trimester, on the day of 
delivery, and postpartum: CD4DimCD25Hi, CD4+CD25HiFoxp3+, and 
CD4+CD25HiCD127-/dim. Additionally, the expression levels of the transcription 
factor Foxp3 in CD4DimCD25Hi Treg were analyzed. We have found that 
CD4DimCD25Hi Treg subset significantly decreased in the pregnant women on the 
day of delivery relative to the 3rd trimester (p < 0.05), and that all Treg subsets 
significantly increased postpartum compared to the 3rd trimester and the day of 
delivery (p < 0.05). Moreover, the Foxp3 expression ratios within the CD4DimCD25Hi 
Treg subset decreased during pregnancy and until delivery compared to those 
measured in the non-pregnant women and significantly increased postpartum 
compared to the 3rd trimester and the day of delivery (p < 0.05). Thus, despite their 
established role in offering immunoprotection to the fetus in early pregnancy, the 
number of circulating Tregs also varies from late pregnancy to the postpartum 
period. Our results offer an explanation for the possible effects of pregnancy on the 
clinical outcomes of some autoimmune diseases or the increased susceptibility to 
infections during the postpartum period. 
 
Keywords 
Regulatory T cells, immunology, Foxp3, immunomodulation, pregnancy 
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Background 
The survival of a semiallogeneic fetus is a unique immunological challenge 
during pregnancy. Regulatory T cells (Tregs) are a specialized T cell subpopulation 
involved in preventing autoimmunity and graft rejection,1 as they are potent 
suppressors of inflammatory immune responses. Additionally, Tregs prevent 
maternal T cell activation against fetal cells, and this protection of the fetus from the 
maternal immune system has been widely reported in both mice and humans.2-4 A 
reduction in maternal Treg populations could cause failure of immunological 
tolerance to the fetus and has been associated with obstetrical complications, such as 
miscarriage, preeclampsia, and preterm labor.5-10  
Although numerous Treg-specific markers have been proposed for mice and 
humans, the transcription factor Foxp3 is still the most consistent marker, and this 
protein seems to be essential for the function of these immunosuppressive cells.11,12 
In humans, the detection of CD4DimCD25Hi, CD4+CD25HiFoxp3+ and 
CD4+CD25HiCD127-/dim T cell populations remains one of the most common 
analytical strategies used to identify Treg subsets.3,13-15 
Treg expansion in the decidua of normal pregnant women is most robust during 
early pregnancy and decreases as term approaches, suggesting that the immune 
regulatory processes that occur at the maternal—fetal interface are dynamic and 
provide immune protection for the fetus.4,16 Variations in Treg numbers during 
human pregnancy occur not only at the decidua but also in the maternal peripheral 
blood.6,17 
Treg subsets in peripheral blood have been explored in normal human pregnancy 
and during the postpartum period in several studies; however, the results have been 
highly variable, with some reports showing a decrease18 or an increase3,10,19-22 in the 
first trimester, a decrease18,23 or an increase3,10,19,20,24 in the second trimester, or a 
decrease3,4,10,18-20,22 or an increase24 in the 3rd trimester and others showing either no 
changes22 or a decline10,24 during labor and a decrease3,10,19 or an increase25 in the 
postpartum period. These discrepancies can be attributed to differences in study 
design, as some studies do not include the postpartum period,4,18,20,22-24 and in others 
not all women contribute samples at all time points.3,10,18-20,22,25 Contrasting reports 
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of Treg patterns may also be attributed to differences in sample size or the use of 
different and sometimes non-specific markers for Tregs subsets. Therefore, the 
currently available data on variations in maternal Treg subsets during pregnancy 
need re-evaluation. Consequently, the aim of the current study was to characterize 
the evolution of Tregs subsets (defined as CD4DimCD25Hi, CD4+CD25HiFoxp3+ and 
CD4+CD25HiCD127-/dim T cells) and the expression of Foxp3 within CD4DimCD25Hi 
Treg subset in the peripheral blood of normal pregnant women from late pregnancy 
through the postpartum period and to compare these measurements with those taken 
from non-pregnant women. 
 
Materials and Methods 
Study population 
This was a prospective observational study that followed healthy pregnant 
women over time to characterize (through cell quantification and phenotype 
identification) peripheral blood Tregs (CD4DimCD25Hi, CD4+CD25HiFoxp3+ and 
CD4+CD25HiCD127-/dim T cells) and Foxp3 expression in CD4DimCD25Hi Tregs from 
late pregnancy through the postpartum period. Furthermore, changes in the above 
parameters were compared between the pregnant women and non-pregnant women 
to identify associations with pregnancy. 
We recruited sequential non-laboring pregnant women with singleton 
pregnancies who were attending routine obstetrical care while in the 3rd trimester of 
pregnancy. Furthermore, we also recruited sequential non-pregnant women who were 
attending routine annual well-woman exams. 
Pregnant women were recruited if their fetuses exhibited appropriate growth (as 
measured by uterine fundal height and by an ultrasound performed after 28 weeks of 
gestation) and if they had no pregnancy complications (either prior or after study 
inclusion). 
The following exclusion criteria were applied to all of the women: diabetes, 
hypertension, autoimmune or vascular disease, infection (human immunodeficiency 
virus, syphilis, or hepatitis B or C), or smoking during the 6 months prior to study 
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inclusion. Furthermore, pregnant women were excluded if they had a pre-term 
delivery (< 37 weeks of gestation), signs of infection, if they required labor 
induction, or if they required administration of prenatal medication (other than 
vitamins and iron supplements). We also excluded non-pregnant women who were 
taking oral contraceptives, as these drugs may influence peripheral blood 
lymphocytes.26 
All of the women were recruited between July 2013 and March 2014 from CUF 
Descobertas Hospital in Lisbon (Portugal). The ethics committee of the hospital 
approved our study protocol, and all the recruited women provided written informed 
consent before study inclusion. 
Study procedures 
To characterize peripheral blood Tregs and Foxp3 expression from late 
pregnancy through the postpartum period, 3 blood samples were collected: the first 
was collected during the 3rd trimester of pregnancy, the second was collected on the 
day of delivery (within 15 minutes after placental expulsion and oxytocin 
administration), and the last was collected during the postpartum period (at least 6 
weeks after delivery). A single peripheral blood sample was taken from the non-
pregnant women at a planned visit, which occurred during the follicular phase of the 
menstrual cycle. 
Demographics, anthropometrics [body mass index (BMI)], obstetric history, and 
systolic and diastolic blood pressures were collected as baseline data for all the 
women. Gestational age (at baseline and at delivery), type of analgesia and/or 
anesthesia, and mode of delivery were collected only for the pregnant women. 
Gender, birth weight, and 1-minute and 5-minute Apgar scores were collected for the 
newborns. 
Flow cytometry analysis and laboratory measurements 
Blood samples (anticoagulated with EDTA) were evaluated by multicolor flow 
cytometry in a BD FACS Calibur (BD Biosciences, San Jose, CA) equipped with 
two lasers (488 nm air-cooled argon-ion laser and 635 nm red diode laser). All 
samples were processed within 24 hours of collection. 
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A BD Multitest™ IMK kit (BD Biosciences) was used to obtain absolute counts 
of lymphocyte subsets and to characterize these subsets according to the 
manufacturer’s instructions. 
For Treg phenotyping, a panel of monoclonal antibodies (mAbs) including anti-
CD3-FITC (clone SK7, BD Biosciences), anti-CD25 PE (clone BC96, Biolegend, 
San Diego, CA), anti-CD4 PerCP Cy5.5 (clone SK3, Biolegend) and anti-CD127 
Alexa Fluor 647 (clone A019D5, Biolegend) antibodies was employed with a lyse-
wash protocol using BD FACS lysing solution (BD Biosciences). The Human FoxP3 
Buffer Set (BD Pharmingen, San Jose, CA) was also used to characterize Foxp3 
expression. In brief, cells were lysed, washed and then incubated with the surface 
mAbs anti-CD4 and anti-CD25 (referred to above). Staining with Anti-Foxp3 Alexa 
Fluor 488 (clone 259D/C7, BD Pharmingen) was performed after fixing and 
permeabilizing the cells with the reagents supplied in the Human FoxP3 Buffer Set 
kit. A minimum of 10,000 CD4 T cells was acquired per tube, and data analysis was 
performed using CellQuest software (BD Biosciences). 
The gating strategies used are described in Figure 1. In brief, CD4 T cells were 
gated within the lymphocyte cluster using a combined Boolean gating strategy. 
Bivariate dot plots of CD25 versus CD127, CD25 versus Foxp3, and CD25 versus 
CD4 were further used to identify CD4DimCD25Hi, CD4+CD25HiFoxp3+, and 
CD4+CD25HiCD127-/dim regulatory subsets, which were quantified as percentages of 
total CD4 T cells. Fluorescence Minus One (FMO) tubes and internal cell 
populations were used as negative controls to assess CD25, CD127 and Foxp3 
positivity.27,28 
The expression of the transcription factor Foxp3 was assessed within the 
CD4DimCD25Hi Treg subset using the geometric mean values of mean fluorescence 
intensity (MFI) units, which were converted into a ratio (MFI of Foxp3 in 
CD4DimCD25Hi Treg / MFI of Foxp3 in CD4- lymphocytes) as previously described 
to reduce the impact of day-to-day variation.29 
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Statistical analysis 
Data normality was assessed using the Shapiro-Wilk test. Baseline data were 
presented as means (±standard deviations) if normally distributed or as medians and 
ranges if not normally distributed. Categorical variables were described using 
absolute and relative frequencies. Treg counts and percentages were presented as 
medians and ranges. If normally distributed, 2 independent groups were compared 
using Student’s t-tests; otherwise, Mann–Whitney U tests were used. If normally 
distributed, paired data were compared using paired Student’s t-tests; otherwise, 
Wilcoxon signed-rank tests were used. For normally distributed data, comparisons 
between more than 2 groups were performed using ANOVA I; otherwise, Kruskal-
Wallis tests were used. Statistical significance was defined by a P-value < 0.05. The 
P-values for the comparisons of Treg subsets and Foxp3 expression levels at 
different time points were adjusted for multiplicity using the Benjamini and Yekutieli 
method.30 All of the data were analyzed using R software, version 3.12 for Windows. 
 
Results 
Baseline characteristics 
Our study included a total of 78 healthy women (43 pregnant and 35 non-
pregnant). The demographic and clinical data collected for all the participants and 
their newborns are presented in Table 1. The mean BMI was 21.5 (±2.8) Kg/m2 for 
the non-pregnant women and 26.2 (±2.8) Kg/m2 for the pregnant women. All the 
women had normal blood pressures [mean systolic blood pressure: 119.8 (±10.5) 
mmHg for the non-pregnant women and 115.7 (±9.3) mmHg for the pregnant 
women; mean diastolic blood pressure: 74.7 (±7.4) mmHg for the non-pregnant 
women and 67.4 (±7.4) mmHg for the pregnant women]. The median time since the 
last pregnancy (regardless of whether the pregnancies were interrupted or resulted in 
a live birth) for the non-pregnant women was 169 (23-449) weeks. For the pregnant 
women, the median gestational age at the 3rd trimester of pregnancy was 33.0 (31-35) 
weeks, and at the delivery day it was 39.0 (37-41) weeks. The group of pregnant 
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women was significantly younger (p < 0.05) and included significantly more 
nulliparous women (p < 0.05) than the group of non-pregnant women. 
All vaginal deliveries were spontaneous and received epidural analgesia during 
labor. All cesarean sections were performed with regional anesthesia. All women 
were discharged from the hospital 2 days after a vaginal delivery or 3 days after a 
cesarean section. Postpartum evaluations were undertaken at a median of 45 (41-58) 
days after delivery. 
Characterization of Tregs 
The Treg characterization results for all of the enrolled women are presented in 
Figure 2. Relative to during the 3rd trimester, on the day of delivery, a significant 
decrease in the percentage of CD4DimCD25Hi Tregs (p < 0.05) was found, but no 
other significant differences were identified for percentages of Tregs between any of 
the other study visits. However, postpartum, there was a significant increase (p < 
0.05) in the absolute counts of Tregs (CD4DimCD25Hi, CD4+CD25HiFoxp3+, and 
CD4+CD25HiCD127-/dim) compared with the values obtained during the 3rd trimester 
and on the day of delivery. The absolute counts and percentages of CD4DimCD25Hi 
Tregs, CD4+CD25HiFoxp3+ Tregs, and CD4+CD25HiCD127-/dim Tregs did not 
significantly differ (p ≥ 0.05) between the non-pregnant and pregnant women at any 
of the study visits. 
Foxp3 expression in CD4DimCD25Hi Tregs 
The ratios for Foxp3 expression in CD4DimCD25Hi Tregs for all of the enrolled 
women are presented in Figure 3. This ratio was significantly lower (p < 0.001) 
during the 3rd trimester and on the day of delivery in the pregnant women compared 
to the non-pregnant women. Postpartum, the ratios of Foxp3 expression in 
CD4DimCD25Hi Tregs significantly increased (p < 0.001) compared to the values 
measured during the 3rd trimester and on the day of delivery, reaching expression 
levels similar to those observed in the control group of non-pregnant women. No 
statistically significant differences (p ≥ 0.05) were identified for this ratio between 
the 3rd trimester and the day of delivery. 
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Discussion 
In the present study, we investigated whether Treg subsets varied in the 
peripheral blood of normal women between late pregnancy and the postpartum 
period. We found that percentages of CD4DimCD25Hi Tregs in pregnant women 
decreased significantly on the day of delivery compared to those measured during the 
3rd trimester (p < 0.05). This variation was not observed in the other tested subsets of 
Tregs (CD4+CD25HiFoxp3+ and CD4+CD25HiCD127-/dim T cells), which can be 
explained by the heterogeneity of Treg populations. For example, Loewendorf et al31 
demonstrated that defining Tregs as CD4+CD25HiCD127-/dim underestimates the 
number of CD4 T cells that express Foxp3. 
Our results are consistent with those of previous human studies showing that 
Treg subsets in peripheral blood decrease on the day of delivery. These studies10,24 
suggest that Tregs play a role in the immunological changes that occur before labor 
and that human labor may be initiated as an effect of the decrease in Tregs. 
Furthermore, estrogen and progesterone appear to impact Treg populations in 
humans. Xiong et al3 showed that Treg subsets in peripheral blood are positively 
correlated with estrogen levels, a relationship that might play an important 
immunomodulatory role during pregnancy. Additionally, another study recently 
demonstrated that membrane progesterone receptor alpha (mPRα) is present on 
Tregs, suggesting an association between the immune system and the initiation of 
human labor; notably, in the referenced study, the highest Treg values were 
measured during the 3rd trimester, and these values decreased on the day of 
delivery.32 
In the present study, we used three analytical strategies to characterize Treg 
substes (CD4DimCD25Hi, CD4+CD25HiFoxp3+ and CD4+CD25HiCD127-/dim T cells) 
and found similar patterns overall, namely, that significantly higher counts of Tregs 
were present in circulating blood in the postpartum period compared to the 3rd 
trimester and the day of delivery (p<0.05). These results are consistent with the 
conclusions of Wegienka et al25 but are inconsistent with earlier studies.3,10,19 The 
increase in absolute Treg counts suggests that an immunosuppressed environment, 
which allows maternal-fetal tolerance in pregnancy, is also present postpartum. It has 
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been suggested that maternal immunological activation starting after delivery and 
progressing with gestational age is related to the progressive fetal-maternal cell 
trafficking that occurs during pregnancy.33 According to our findings, we 
hypothesize that Treg expansion is a potential physiological mechanism for 
downregulating the activation of maternal immunological events (i.e., causing less 
susceptibility to systemic inflammatory responses) that occur during the postpartum 
period. 
We also studied Foxp3 expression levels in CD4DimCD25Hi Tregs. We found 
that during pregnancy and until delivery Foxp3 expression was lower within the 
CD4DimCD25Hi Tregs in the pregnant women compared to the non-pregnant women. 
It has been reported that progesterone and 17β-estradiol reduce Foxp3 expression in 
Tregs in mid-pregnancy.23 Our data are consistent with these findings, which 
probably extend through the 3rd trimester and delivery. Postpartum, Foxp3 
expression increased significantly compared to the 3rd trimester and the day of 
delivery, reaching levels similar to those measured in the control group of non-
pregnant women. This confirms that pregnancy causes modulation of Foxp3 
expression.  
Furthermore, postpartum, we observed fluctuations in Foxp3 expression that 
showed a similar pattern to one previously described for CD24HiCD38Hi regulatory B 
cells in healthy human pregnancies, namely, absolute counts and percentages 
increased significantly compared to those measured during the 3rd trimester of 
pregnancy and on the day of delivery.34 These results are concordant with recent 
studies in human cell lines demonstrating that regulatory B cells play an important 
role in Treg differentiation by increasing Foxp3 expression in these cells.35,36 
Our study included only women with a normal singleton pregnancy between 37 
and 41 weeks of gestation to obtain a relatively homogenous sample and reduce 
potential bias. In addition, all the enrolled pregnant women contributed samples at all 
of the study’s time points (3rd trimester, delivery day and postpartum). Preferably, 
samples from additional time points, such as during the first and second trimesters of 
pregnancy, would be included, as well as the monitoring of women from before 
becoming pregnant through the postpartum period. However, these additional time 
points were beyond the scope of the current study. 
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We also accounted for the phase of the menstrual cycle during which the 
samples were collected from the control group. Peripheral blood samples were 
collected from the non-pregnant women during the follicular phase of the menstrual 
cycle, as hormone status during the luteal phase is comparable to that during 
pregnancy.37 However, a previous study38 reported that Treg subsets expand during 
the follicular phase, reaching a peak immediately before ovulation (to induce 
immune tolerance to facilitate implantation), and then decline in the subsequent 
luteal phase. This may have contributed to the absence of significant differences in 
Treg numbers between the non-pregnant and pregnant groups. Additionally, because 
crucial immunological events are more likely to occur at the maternal—fetal 
interface, it is important that future studies compare Tregs in both the peripheral 
blood and the decidua from the same healthy pregnant women. 
In the current study, we performed complementary measurements of both 
percentages and absolute counts of different Treg subsets. The use of percentages 
allows for the interpretation of the relative fluctuations in Treg cell subsets from late 
pregnancy through the postpartum period. Although absolute counts were also 
measured, pregnancy is characterized by variable degrees of hemodilution, during 
which changes in total numbers of circulating Tregs may not necessarily reflect 
variations in these subsets. Further functional and epigenetic experiments are 
required to identify T cells expressing Foxp3 as Tregs because activated T cells 
without regulatory function can also present a Foxp3-positive phenotype.39 
In conclusion, we found that CD4+CD25Hi Treg subset decrease significantly on 
the day of delivery compared to those measured during the 3rd trimester in healthy 
pregnant women. We also showed significant increases in circulating Treg subsets 
and in Foxp3 expression in CD4DimCD25Hi Treg subset in the postpartum period 
compared to during the 3rd trimester and on the day of delivery. Our results support 
that Tregs, despite their established immunoprotective role for the fetus in early 
pregnancy, present dynamic behavior during late pregnancy and in the postpartum 
period. The observed postpartum increases in Treg subsets could explain the 
increased susceptibility to infections that occurs during this period and the possible 
interference of pregnancy with the clinical outcomes of some autoimmune diseases. 
We suggest that variations in Treg numbers from late pregnancy through the 
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postpartum period are reflective of pregnancy’s effect on the maternal immune 
system and may permanently affect the immune status of a woman and have 
implications for future pregnancies. 
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Table 1 – Demographic and clinical characteristics of non-pregnant women and 
pregnant women and their newborns 
 Non-pregnant woman 
(n=35) 
Pregnant women 
(n=43) 
Age in years, median 
(range) 
35.0 (20-40) 32.0 (25-41)* 
Parity: nulliparous, n (%) 5 (14.3) 24 (55.8)* 
Gestational age in weeks, median (range) 
3rd trimester  33.0 (31-35) 
Day of delivery  39.0 (37-41) 
Postpartum evaluation in 
days, median (range) 
 45 (41-58) 
Mode of delivery, n (%) 
Vaginal  18 (41.8) 
Cesarean  25 (58.2) 
Newborns 
Birth weight in 
grams, mean (± 
standard deviation) 
 3,265.0 (±393.5) 
Gender: Male, n (%)  22 (51) 
APGAR score, 
median (range) 
  
1-minute Apgar 
score 
 9 (6-10) 
5-minute Apgar 
score 
 10 (9-10) 
*Statistically significant differences (p<0.05) identified between the healthy pregnant 
women and the healthy non-pregnant women 
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Figure 1 - Gating strategy for the identification of Tregs. a. Lymphocyte gate on 
FSC/SSC. b. Identification of CD4 T cells within lymphocyte populations 
(CD3+CD4+ T cells). c. Identification of CD4+CD25HiCD127-/dim regulatory T cells. 
d and e. Identification of CD4+CD25HiFoxp3+ regulatory T cells with dot plots of 
Fluorescence Minus One (FMO) (d) and Foxp3 (e) tubes. f. CD4 vs. CD25 dot plot 
showing the identification of CD4DimCD25Hi regulatory T cells. g. Histogram for the 
evaluation of Foxp3 expression in CD4DimCD25Hi regulatory T cells (red line), 
overlaid on that for the expression of Foxp3 within CD4- lymphocytes (black line). 
Tregs, regulatory T cells. 
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Figure 2 - Absolute counts and percentages of Tregs in peripheral blood samples. 
Delivery, within 15 minutes after placental expulsion; postpartum, at least 6 weeks 
after delivery; Tregs, regulatory T cells. The bottom of the box represents the 25th 
percentile, the top of the box represents the 75th percentile, the horizontal line inside 
the box represents the median, the bottom whiskers represent the minimum value, 
and the top whiskers represent the maximum value. * p<0.05; ** p<0.001 
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Figure 3 - Foxp3 expression in CD4DimCD25Hi Tregs. Delivery, within 15 minutes 
after placental expulsion; postpartum, at least 6 weeks after delivery; Tregs, 
regulatory T cells. The bottom of the box represents the 25th percentile, the top of 
the box represents the 75th percentile, the horizontal line inside the box represents 
the median, the bottom whiskers represent the minimum value, and the top whiskers 
represent the maximum value. * p<0.05; ** p<0.001 
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Final Remarks 
Pregnancy poses a challenge to the maternal immune system because it requires 
the development of tolerance to a genetically foreign fetus and simultaneously must 
protect the mother and the fetus against infection. These requirements necessitate 
tight regulation of the maternal immune system during the different stages of 
pregnancy. Although several subsets of B and T cells have been shown to have 
regulatory functions via the production of anti-inflammatory and pro-inflammatory 
cytokines, their occurrence and function during late pregnancy and the postpartum 
period remain unclear.41,42,48,85-95,109-118 Therefore, the main aim of this research was 
to analyze (i.e., cell quantification and phenotypic identification) B and T cell 
populations, including their regulatory subsets, in the peripheral blood of healthy 
pregnant women compared with non-pregnant women from the 3rd trimester to the 
postpartum period. 
Eighty-three patients were selected for observational prospective studies 
according to the eligibility criteria and allocated into two groups: one group of 
pregnant women (n = 48) and a non-pregnant women control group (n = 35). During 
follow-up, only 5 pregnant women dropped out from the study: 3 because they had 
preterm deliveries (<37 weeks of gestation); 1 that did not come back after collecting 
blood at the 1st time point (3rd trimester of pregnancy); and 1 woman with a previous 
caesarean who had an intrapartum uterine rupture during labor with bleeding 
requiring transfusion prior to the sampling. 
We found that the progression of a normal pregnancy from the 3rd trimester to 
the postpartum period was accompanied by variation in several B and T cell types in 
the peripheral blood. In chapter III, we showed that the CD19+ B cell population 
decreased in the late stage of pregnancy, between the 3rd trimester and delivery. 
These results are consistent with those of several previous studies conducted in 
humans.85-95 Moreover, a detailed search of the relevant literature indicated that, to 
our knowledge, this is the first study to characterize the circulating B cell 
compartment during human pregnancy while taking into account the maturational 
stages of the different B cell subsets. We found that the absolute counts of several B 
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cell subsets (transitional, unswitched memory, resting memory B cells, and 
plasmablasts) were significantly reduced in the 3rd trimester and on the day of 
delivery, compared to non-pregnant women, and increased during the postpartum 
period to normal values. However, the percentages of naïve B cells increased during 
the 3rd trimester and on the day of delivery, and decreased in the postpartum period 
to similar levels to those detected in non-pregnant women. This expansion of naïve B 
cells during pregnancy has been previously described in pregnant mice.82 Finally, we 
also showed in chapter III that the absolute counts and percentages of the 
CD24HiCD38Hi Breg subset were significantly higher in the postpartum period of 
pregnant women compared with non-pregnant women, after decreasing during the 3rd 
trimester and on the day of delivery. 
Taken together, the results shown in chapter III support the conclusion that late 
pregnancy in humans is accompanied by lower levels of B cell subsets and a relative 
increase in naïve B cells in the peripheral blood. We hypothesized that these 
observations could result from two conditions: the reduction of the generation or 
differentiation of B cells, which might be driven by female sex hormones (e.g., 
progesterone, estrogen)156,157; or the increase in the migration of B cells from the 
peripheral blood to other organs.158-160 Further studies are required to ascertain the 
biological meaning of B cell lymphopenia in late pregnancy, but it is probably 
related to the mechanism that regulates the maternal immune tolerance to the fetus. 
This hypothesis is supported by the observations in chapter III confirming that most 
B cell subsets appear to revert to normal levels during the postpartum period, while 
the percentages of CD24HiCD38Hi Bregs were significantly higher in the postpartum 
period compared with non-pregnant women. Because B cell lymphopoiesis could be 
under endocrine regulation during pregnancy, our results might be explained by the 
decline in hormonal levels that typically occurs in the postpartum period, which 
might have lead both to B cell lymphopoiesis recovery and to B cell activation.82,156 
Although the mechanism that triggers the postpartum increase in the 
CD24HiCD38Hi Breg subset remains unclear, these results could have clinical 
importance for the treatment of patients who might benefit from an increase in B cell 
lymphopoiesis (e.g., transplant or immunocompromised patients).156  
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We are aware that this study had some limitations. All of the pregnant women in 
our study received epidural analgesia during labor and/or regional anesthesia. Such 
anesthetic techniques are unlikely to cause important changes in immune cell counts 
because regional administration is generally associated with low plasma levels of the 
administered drugs. Ideally, samples collected before pregnancy would have been 
compared with samples collected during pregnancy in the same individuals; 
however, this experimental design would have been very difficult for us to achieve 
from a practical perspective. Nevertheless, the strength of our research is 
underscored by its pioneering status as the first investigation conducted in humans to 
characterize the circulating B cell compartment during pregnancy, while taking into 
account the maturational stages of the different B cell subsets. In addition, the 
success of this ambitious and arduous project was only possible because of a team of 
highly motivated and available people (24 hours a day). Accuracy was maintained 
because the same research team performed the clinical monitoring (including 
deliveries) and laboratory tests, using very strict criteria and protocols. 
In chapter IV, we found that Treg subset counts, namely CD4DimCD25Hi, 
CD4+CD25HiFoxp3+ and CD4+CD25HiCD127-/dim, increased in the postpartum period 
compared with the 3rd trimester and the day of delivery. These results are in 
accordance with the conclusions of Wegienka et al.,118 but are inconsistent with 
earlier studies.42,112,115 Despite the limitations of our study, namely the hemodilution 
effect and heterogeneity of the Treg subsets, additional data regarding the analysis of 
Foxp3,161,162 a transcription factor that is essential for Treg induction and stability, 
support the conclusions shown in this study. Accordingly, the Foxp3 expression ratio 
in the CD4DimCD25Hi Treg subset increased significantly in the postpartum period, 
after decreasing during pregnancy and on the day of delivery compared with the 
levels measured in non-pregnant women. Furthermore, these fluctuations in Foxp3 
expression and in Treg subset levels showed a similar pattern to those previously 
found in chapter III for the CD24HiCD38Hi Breg subset (i.e., increased levels during 
the postpartum period). Hence, the results shown in chapters III and IV provide 
further evidence that Breg play an important role in Treg differentiation, probably by 
promoting Foxp3 expression in these cells. This assumption is also supported by 
recent studies conducted in human cell lines.163,164 
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The increase in circulating Treg subsets and Foxp3 expression in the postpartum 
period compared with the 3rd trimester and the day of delivery, also could be a 
consequence of the action of known Treg modulators, such as hormones and 
cytokines,107 driven by a yet unclear mechanism. It has been reported that the female 
sex hormones progesterone and estradiol reduce Foxp3 expression in Tregs during 
mid pregnancy.116 Our data are consistent with these findings, which probably extend 
through the 3rd trimester and delivery. During the postpartum period, Foxp3 
expression increases significantly compared with the 3rd trimester and the day of 
delivery, reaching levels similar to those measured in the control group of non-
pregnant women. This phenomenon confirms that pregnancy results in a modulation 
of Foxp3 expression within the CD4DimCD25Hi Treg subset. However, the increase in 
Treg suggests the presence of an immunosuppressed environment, permitting 
maternal-fetal tolerance during pregnancy, as well as the postpartum period. 
Strikingly, labor has been linked to the progression of maternal-fetal immune cell 
trafficking with gestational age, which might trigger the activation of maternal 
immune cells.165 According to the findings presented in chapter IV, we hypothesize 
that Treg expansion in the postpartum period is a potentially physiological 
mechanism that leads to the down regulation of maternal immunological events that 
are activated during delivery (i.e., reducing susceptibility to systemic inflammatory 
responses). 
The results presented both in chapters IV and III included only women with a 
normal singleton pregnancy between 37 and 41 weeks of gestation to obtain a 
relatively homogenous sample and to reduce potential bias. In addition, all enrolled 
pregnant women contributed samples at all of the study time points (3rd trimester, 
delivery day and postpartum). We also accounted for the phase of the menstrual 
cycle during which the samples were collected from the non-pregnant women. 
Peripheral blood samples were collected from this control group during the follicular 
phase of the menstrual cycle because hormonal status during the luteal phase is 
comparable to that during pregnancy.166 However, a previous study167 reported that 
Treg subsets expand during the follicular phase, peaking immediately before 
ovulation (to induce immune tolerance to facilitate implantation), and then decline in 
the subsequent luteal phase. This phenomenon may have contributed to the absence 
of significant differences in Treg numbers between the non-pregnant and pregnant 
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groups. Preferably, samples from additional time points, such as during the first and 
second trimesters of pregnancy, would be included, as well as samples obtained 
during the monitoring of women before becoming pregnant through the postpartum 
period. However, these additional time points are beyond the scope of the current 
analyses. 
In chapter V, we addressed the question of whether normal labor has an effect 
on maternal circulating T cell subsets, Treg, and Breg. Specifically, differences 
between spontaneous vaginal deliveries (after completion of labor) and elective 
cesareans (no labor) were analyzed in the peripheral blood of healthy women. We 
found that labor had no major effects on the levels of the majority of B and T cell 
subsets, although it was associated with lower CD19+ B cell counts. This decrease in 
CD19+ B cells may indicate the presence of obstacle to their differentiation, a change 
in their survival, or selective migration of these cells out of the peripheral blood. 
Indeed, previous studies support the hypothesis that the reduced counts of maternal 
immune cells result from their migration into the decidua during labor.158,168 We 
hypothesize that during labor, recruitment events are more intense. In chapter V, we 
showed that spontaneous vaginal deliveries were associated with lower counts of 
NKT-like cells. To our knowledge, this finding has not been previously described 
during labor. In fact, data concerning the function of NKT-like cells in the 
immunomodulatory events associated with pregnancy are limited.103,105 Further 
research is necessary to investigate the precise functions of these cells during labor. 
However, similarly to B cells, NKT-like cells might also migrate selectively to the 
decidua during labor, resulting in a decrease in these cells in the peripheral blood. 
Nevertheless, spontaneous vaginal deliveries and elective cesareans did not seem 
to have significantly different impacts on the absolute counts or percentages of the 
majority of B and T cell subsets in the peripheral blood. In fact, these results appear 
to be inconsistent with those of previous studies in humans, suggesting that Treg play 
a role in immunological changes that occur before labor and that human labor may 
be initiated by the decrease in Treg.115,117 Several factors could explain our 
observations. First, it has been shown that a significantly higher percentage of 
activated T cells are present in the decidua rather than in peripheral blood as a result 
of the local expansion of these cells.108 Thus, any significant variation in immune 
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cells might not be detected in maternal peripheral blood on the day of delivery. In 
addition, the study could be limited by the sample size of pregnant women who gave 
birth by vaginal delivery (n = 18) or elective cesarean (n = 14). Furthermore, recent 
research in humans has shown that absolute counts of Treg and estrogen levels 
increase progressively in the peripheral blood from early to late pregnancy42 and 
decrease after delivery.42,117 This phenomenon suggests that Tregs might play a role 
in the immunological changes that occur before delivery rather than during or 
immediately after labor. Accordingly, Breg were shown to expand in early pregnancy 
when immunosuppression is probably most necessary.15 Therefore, we hypothesize 
that, like Treg, Breg are probably not directly involved in immunological 
mechanisms related to labor. 
The main limitation of our study presented in chapter V was that there were 
significantly more nulliparous patients who delivered their newborns vaginally than 
by elective cesarean. Nonetheless, our sample was homogenous because we only 
included pregnant woman who had singleton pregnancies between 37 and 41 weeks 
of gestation. Furthermore, we used standardized protocols for the management of 
vaginal deliveries and elective cesareans, with no induction of labor or intravenous 
analgesia. Studies with larger sample sizes may be required to further investigate the 
impact of labor on the cells of the maternal immune system. 
The results shown in chapter V together with those described in chapters III and 
IV provide important answers to our research questions. First, we found that the 
levels of the CD24HiCD38Hi Breg and Treg subsets also varied during the postpartum 
period, despite their best known involvement in the establishment of early 
pregnancy. Second, this variation was not due to labor, as evidenced by the absence 
of differences in circulating Breg and Treg subset levels between women with 
spontaneous vaginal labor and elective cesareans on the day of delivery. This finding 
indicates that labor alone does not influence the expansion of B cells and T cells, nor 
is a consequence of their suppression, bearing in mind that phenomena in the 
peripheral blood do not necessarily reflect those in the placenta. Nevertheless, labor 
has been likened to an immunological reaction that results in the recruitment of 
immune cells not only to the maternal-fetal interface but also to the peripheral 
blood.98 Finally, the increase in the Breg and Treg subsets during the postpartum 
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period suggest a regulatory mechanism for the suppression of immune cell activation 
events after the day of delivery that is not triggered by labor “per se”. These results 
might also explain the increased susceptibility to infections that occur during the 
postpartum period in healthy women. 
In conclusion, the present results demonstrate that maternal immunomodulation 
also occurs during late pregnancy and postpartum period and is associated with an 
interplay between different B and T cell types, especially Breg and Treg. These 
findings may facilitate the future identification of new strategies for the diagnosis 
and treatment of pregnancy-associated disturbances, as well as mechanisms 
underlying maternal responses to infection and vaccination. 
The use of maternal immunization to protect the health of the pregnant woman, 
her fetus, and the infant, has increased over the past decade. The efficacy of maternal 
vaccines relies on the secretion of antibodies at the maternal–fetal interface. The 
recent resurgence of pertussis and diphtheria has been reported in several 
industrialized countries with a high associated morbidity and mortality, occurring 
primarily in young infants.169 These events have resulted in policy changes for 
vaccines aimed at protecting both mothers and their infants during the first months of 
life, and many health authorities are now recommending certain immunizations 
during pregnancy.170 These new strategies have been reinforced by a recent study 
demonstrating that tetanus, diphtheria and pertussis vaccination during pregnancy 
increases antibody titers against diphtheria and pertussis, which may prevent 
neonatal pertussis infection.171 In Portugal, it is actually recommended that pregnant 
women be vaccinated with a combined vaccine against pertussis, tetanus and 
diphtheria, ideally at 32 weeks. This vaccination scheme for pregnant women is 
planned for inclusion in the National Immunization Program for 2017.172 According 
to health entities, the recommended optimal timing for this specific vaccination is 
between 27 and 36 weeks of gestation. In our study with normal pregnant women 
during their 3rd trimester, we identified quantitative changes in the peripheral B cell 
compartment while considering the different maturational stages. Thus, it is likely 
that the maternal response to vaccination during this critical window may differ 
between pregnant and non-pregnant women. Therefore, the impact of pregnancy-
associated changes in the B cell compartment on humoral immune function should 
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be carefully clarified. These basic immunological insights can be useful for the 
improvement of maternal vaccination programs to increase their safety and 
efficiency. 
Future perspectives 
Further studies in the near future should include a larger sample size to ensure a 
more homogenous distribution between pregnant and non-pregnant women with 
respect to age and parity. In addition, it would be interesting to investigate samples 
from additional time points in the same individuals, such as during the first and 
second trimesters of pregnancy, as well as before becoming pregnant. 
Because crucial immunological events are more likely to occur at the maternal-
fetal interface,2,49 it is important that future studies compare B and T cells in both 
peripheral blood and at the decidua in the same healthy pregnant women. The 
combination of these analyses would discriminate whether the variations in some 
immune cell populations result from their selective cellular migration out of the 
peripheral blood or from differences in differentiation events. 
In future research, it will also be important to fully characterize the regulatory 
functions of the B and T cell subsets. Specifically, it will be essential to examine T 
cells expressing Foxp3 in relation to their regulatory activity because activated T 
cells without regulatory functions can also present a Foxp3-positive phenotype.173 
Moreover, it will be interesting to determine whether the presence or absence of 
labor has different effects on the immune system of pregnant patients with 
autoimmune disorders and might eventually affect their clinical outcomes. In 
addition, it will be important to investigate whether the characterization of B cell 
subsets can facilitate the identification of risk markers for the development of 
obstetric complications in pregnant women with or without autoimmune diseases. In 
this context, it will also be important to clarify the role of B-cell activating factor 
(BAFF), an essential regulator of B cell maturation and function. Nevertheless, our 
group is currently undertaking a preliminary analysis of the BAFF levels in all of the 
samples collected during our study.  
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Several findings have supported the importance of female sex hormones, namely 
estrogen and progesterone, in the modulation of B cells and T cells during human 
pregnancy. Specifically, Xiong et al.42 has shown that Treg subsets in the peripheral 
blood are positively correlated with estrogen levels, a relationship that might play an 
important immunomodulatory role during pregnancy. Another study recently 
demonstrated that membrane progesterone receptor alpha is present on Treg, 
suggesting an association between the immune system and the initiation of human 
labor.119 Future research addressing the mechanism underlying the activation and 
modulation of Breg and Treg, mediated by hormones, could facilitate the design of 
new approaches for the treatment of disturbances related to pregnancy or 
autoimmune diseases. 
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